Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).

Barequet IS, Zehavi-Dorin T, Bourla N, Tamarin I, Moisseiev J, Salomon O.

Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2671-2676. doi: 10.1007/s00417-019-04488-8. Epub 2019 Oct 22.

PMID:
31641883
2.

Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery.

Salomon O, Budnik I, Avishai E, Tamarin I, Bashari D, Dardik R, Livnat T.

Thromb Haemost. 2019 Dec;119(12):1927-1932. doi: 10.1055/s-0039-1696685. Epub 2019 Sep 7.

PMID:
31493780
3.

A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.

Shavit-Stein E, Sheinberg E, Golderman V, Sharabi S, Wohl A, Gofrit SG, Zivli Z, Shelestovich N, Last D, Guez D, Daniels D, Gera O, Feingold K, Itsekson-Hayosh Z, Rosenberg N, Tamarin I, Dori A, Maggio N, Mardor Y, Chapman J, Harnof S.

Front Neurol. 2018 Dec 17;9:1087. doi: 10.3389/fneur.2018.01087. eCollection 2018.

4.

The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro.

Golderman V, Shavit-Stein E, Tamarin I, Rosman Y, Shrot S, Rosenberg N, Maggio N, Chapman J, Eisenkraft A.

PLoS One. 2016 Sep 30;11(9):e0163787. doi: 10.1371/journal.pone.0163787. eCollection 2016.

5.

Thromboelastography during coronary artery bypass grafting surgery of severe hemophilia A patient - the effect of heparin and protamine on factor VIII activity.

Misgav M, Mandelbaum T, Kassif Y, Berkenstadt H, Tamarin I, Kenet G.

Blood Coagul Fibrinolysis. 2017 Jun;28(4):329-333. doi: 10.1097/MBC.0000000000000575.

PMID:
27273141
6.

Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice.

Shnerb Ganor R, Harats D, Schiby G, Gailani D, Levkovitz H, Avivi C, Tamarin I, Shaish A, Salomon O.

Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):475-81. doi: 10.1161/ATVBAHA.115.306954. Epub 2016 Jan 21.

7.

Assessment of Functional Fibrinolysis in Cord Blood Using Modified Thromboelastography.

Sidlik R, Strauss T, Morag I, Shenkman B, Tamarin I, Lubetsky A, Livnat T, Kenet G.

Pediatr Blood Cancer. 2016 May;63(5):839-43. doi: 10.1002/pbc.25865. Epub 2016 Jan 8.

PMID:
26749087
8.

The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency.

Livnat T, Shenkman B, Martinowitz U, Zivelin A, Dardik R, Tamarin I, Mansharov R, Budnik I, Salomon O.

Thromb Res. 2015 Aug;136(2):465-73. doi: 10.1016/j.thromres.2015.06.025. Epub 2015 Jun 19.

PMID:
26160656
9.

Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.

Shenkman B, Livnat T, Budnik I, Tamarin I, Einav Y, Martinowitz U.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):729-33. doi: 10.1097/MBC.0b013e32835897d5.

PMID:
22918041
10.

Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery.

Livnat T, Shenkman B, Spectre G, Tamarin I, Dardik R, Israeli A, Rivkind A, Shabtai M, Marinowitz U, Salomon O.

Blood Coagul Fibrinolysis. 2012 Jul;23(5):379-87. doi: 10.1097/MBC.0b013e328352e8e2.

PMID:
22527290
11.

The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.

Shenkman B, Livnat T, Lubetsky A, Tamarin I, Budnik I, Einav Y, Martinowitz U.

Blood Coagul Fibrinolysis. 2012 Jul;23(5):370-8. doi: 10.1097/MBC.0b013e328352cb3f.

PMID:
22498982
12.

Severe factor X deficiency in three unrelated Palestinian patients is caused by homozygosity for the mutation c302delG-correlation with thrombin generation and thromboelastometry.

Livnat T, Shenkman B, Kenet G, Tamarin I, Gillis S, Varon D, Iijima K, Zivelin A, Salomon O.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):673-9. doi: 10.1097/MBC.0b013e32834ad785.

PMID:
22008904
13.

Point of care testing in children undergoing cardiopulmonary bypass.

Tirosh-Wagner T, Strauss T, Rubinshtein M, Tamarin I, Mishaly D, Paret G, Kenet G.

Pediatr Blood Cancer. 2011 May;56(5):794-8. doi: 10.1002/pbc.22803. Epub 2010 Dec 15.

PMID:
21370413
14.

Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.

Livnat T, Zivelin A, Tamarin I, Guetta V, Salomon O.

Blood Coagul Fibrinolysis. 2009 Dec;20(8):661-6. doi: 10.1097/MBC.0b013e32832ff595.

PMID:
19730246
15.

Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.

Livnat T, Tamarin I, Mor Y, Winckler H, Horowitz Z, Korianski Y, Bar-Zakay B, Seligsohn U, Salomon O.

Thromb Haemost. 2009 Sep;102(3):487-92. doi: 10.1160/TH09-03-0172.

PMID:
19718468
16.

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors.

Kenet G, Lubetsky A, Luboshitz J, Ravid B, Tamarin I, Varon D, Martinowitz U.

Haemophilia. 2009 Sep;15(5):1065-73. doi: 10.1111/j.1365-2516.2009.02043.x. Epub 2009 May 26.

PMID:
19486172
17.

Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib.

Shenkman B, Rubinstein E, Dardik R, Tamarin I, Savion N, Varon D.

Platelets. 1999;10(1):36-44.

PMID:
16801069
18.

Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.

Levy Y, Shenkman B, Tamarin I, Pauzner R, Shoenfeld Y, Langevitz P, Savion N, Varon D.

Arthritis Rheum. 2005 Dec;52(12):4011-7.

19.

Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency.

Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U.

Blood Coagul Fibrinolysis. 2005 Jan;16(1):37-41.

PMID:
15650544
20.

Inherited factor XI deficiency confers no protection against acute myocardial infarction.

Salomon O, Steinberg DM, Dardik R, Rosenberg N, Zivelin A, Tamarin I, Ravid B, Berliner S, Seligsohn U.

J Thromb Haemost. 2003 Apr;1(4):658-61.

21.

Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow condition.

Shenkman B, Inbal A, Tamarin I, Lubetsky A, Savion N, Varon D.

Br J Haematol. 2003 Feb;120(4):597-604.

PMID:
12588345
22.

Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions.

Shenkman B, Varon D, Tamarin I, Dardik R, Peisachov M, Savion N, Rubinstein E.

J Med Microbiol. 2002 Sep;51(9):747-754. doi: 10.1099/0022-1317-51-9-747.

PMID:
12358065
23.

Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience.

Lubetsky A, Martinowitz U, Luboshitz J, Kenet G, Keller N, Tamarin I, Inbal A.

Haemophilia. 2002 Sep;8(5):622-8.

PMID:
12199669
24.

Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins.

Dardik R, Shenkman B, Tamarin I, Eskaraev R, Harsfalvi J, Varon D, Inbal A.

Thromb Res. 2002 Feb 15;105(4):317-23.

PMID:
12031826
25.

Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants.

Linder N, Shenkman B, Levin E, Sirota L, Vishne TH, Tamarin I, Dardik R, Lubin D, Savion N, Varon D.

Arch Dis Child Fetal Neonatal Ed. 2002 Mar;86(2):F127-30.

26.

Adherence properties of Staphylococcus aureus under static and flow conditions: roles of agr and sar loci, platelets, and plasma ligands.

Shenkman B, Rubinstein E, Cheung AL, Brill GE, Dardik R, Tamarin I, Savion N, Varon D.

Infect Immun. 2001 Jul;69(7):4473-8.

27.
28.

Testing the effect of GPIIb-IIIa antagonist in patients undergoing carotid stenting: correlation between standard aggregometry, flow cytometry and the cone and plate(let) analyzer (CPA) methods.

Shenkman B, Schneiderman J, Tamarin I, Kotev-Emeth S, Savion N, Varon D.

Thromb Res. 2001 May 15;102(4):311-7. No abstract available.

PMID:
11369424
29.
30.

S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model.

Gurevitz O, Eldar M, Skutelsky E, Tamarin I, Shenkman B, Eskaraev R, Castel D, Loscalzo J, Inbal A.

Thromb Haemost. 2000 Nov;84(5):912-7.

PMID:
11127876
32.

Blood irradiation by He-Ne laser induces a decrease in platelet responses to physiological agonists and an increase in platelet cyclic GMP.

Brill AG, Shenkman B, Brill GE, Tamarin I, Dardik R, Kirichuk VF, Savion N, Varon D.

Platelets. 2000 Mar;11(2):87-93.

PMID:
10938886
33.
34.

Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation.

Dardik R, Varon D, Tamarin I, Zivelin A, Salomon O, Shenkman B, Savion N.

Thromb Haemost. 2000 Feb;83(2):338-44.

PMID:
10739396
35.

Staphylococcus aureus adherence to thrombin-treated endothelial cells is mediated by fibrinogen but not by platelets.

Shenkman B, Rubinstein E, Tamarin I, Dardik R, Savion N, Varon D.

J Lab Clin Med. 2000 Jan;135(1):43-51.

PMID:
10638693
36.

[Effect of He-Ne laser irradiation on platelet activation and aggregation].

Brill' AG, Brill' GE, Kirichuk VF, Shenkman B, Tamarin I, Dardik R, Varon D, Savion N.

Biull Eksp Biol Med. 1999 Jul;128(7):48-50. Russian. No abstract available.

PMID:
10485049
37.

Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: in vitro and ex vivo inhibition of platelet function.

Inbal A, Gurevitz O, Tamarin I, Eskaraev R, Chetrit A, Novicov I, Feldman M, Varon D, Eldar M, Loscalzo J.

Blood. 1999 Sep 1;94(5):1693-700.

PMID:
10477694
38.

Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor.

Shenkman B, Linder N, Savion N, Tamarin I, Dardik R, Kennet G, German B, Varon D.

Pediatr Res. 1999 Feb;45(2):270-5.

PMID:
10022601
39.

Cone and platelet analyser (CPA): a new test for the prediction of bleeding among thrombocytopenic patients.

Kenet G, Lubetsky A, Shenkman B, Tamarin I, Dardik R, Rechavi G, Barzilai A, Martinowitz U, Savion N, Varon D.

Br J Haematol. 1998 May;101(2):255-9.

PMID:
9609519
40.

Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions.

Varon D, Lashevski I, Brenner B, Beyar R, Lanir N, Tamarin I, Savion N.

Am Heart J. 1998 May;135(5 Pt 2 Su):S187-93.

PMID:
9588399
41.
42.

Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.

George J, Blank M, Gilburd B, Hojnik M, Shenkman B, Tamarin I, Varon D, Matsuura E, Koike T, Shoenfeld Y.

Int Immunol. 1997 Jun;9(6):913-21.

PMID:
9199975
43.

A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions.

Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N.

Thromb Res. 1997 Feb 15;85(4):283-94.

PMID:
9062952
44.

[Correction by transfusion of hemostatic disorders].

Tamarin IV.

Gematol Transfuziol. 1995 Jan-Feb;40(1):25-7. Russian. No abstract available.

PMID:
7615250
45.

[The intensive therapy of multiple organ failure in myelotoxic agranulocytosis in a patient with acute leukemia].

Shulutko EM, Fedanov AV, Tamarin IV, Gorelov VG, Pivnik AV, Kremenetskaia AM, Gorodetskiń≠ VM, Kozhurin SV.

Ter Arkh. 1992;64(7):111-4. Russian. No abstract available.

PMID:
1440356
46.

[Activation of factor VII as a global marker of thrombophilic conditions].

Barkagan ZS, Eremin GF, Mazyrko AV, Tamarin IV.

Kardiologiia. 1989 Jun;29(6):121-5. Review. Russian. No abstract available.

PMID:
2674517
47.

[Restoration of the microcirculation in the treatment of acute destructive lung diseases].

Shoń≠khet IaN, Barkagan ZS, Roshchev IP, Bondarenko IG, Tamarin IV.

Klin Med (Mosk). 1988 Mar;66(3):51-5. Russian. No abstract available.

PMID:
3392924
48.

[Assessment of the degree of damage to erythrocytes in disseminated intravascular blood coagulation].

Barkagan ZS, Tamarin IV.

Lab Delo. 1988;(4):35-9. Russian. No abstract available.

PMID:
2457739
49.
50.

[Combined 2d-type TAR syndrome, factor X deficiency, immune deficiency and mitral valve prolapse].

Barkagan ZS, Tamarin IV, Kondakova GB, Aleksandrova AIu, Bespal'ko IA.

Ter Arkh. 1986;58(9):137-41. Russian. No abstract available.

PMID:
3787484

Supplemental Content

Loading ...
Support Center